Michael J Kovacs
Overview
Explore the profile of Michael J Kovacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
3856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Le Gal G, Kovacs M, Bertoletti L, Couturaud F, Dennie C, Hirsch A, et al.
Ann Intern Med
. 2021 Nov;
175(1):29-35.
PMID: 34807722
Background: The incidence of pulmonary embolism has been increasing, but its case-fatality rate is decreasing, suggesting a lesser severity of illness. The clinical importance of patients with pulmonary embolism isolated...
12.
Caiano L, Sharkey R, Rodger M, Kovacs M, Le Gal G, Delluc A
Eur Respir J
. 2021 Nov;
59(2).
PMID: 34795036
No abstract available.
13.
Delluc A, Ghanima W, Kovacs M, Shivakumar S, Kahn S, Sandset P, et al.
J Thromb Haemost
. 2021 Sep;
20(1):126-132.
PMID: 34564938
Background: Statins may reduce the risk for recurrent venous thromboembolism (VTE); however, no randomized trials have explored this hypothesis. We performed a pilot randomized trial to determine feasibility of recruitment...
14.
Kovacs M, Lazo-Langner A
J Thromb Haemost
. 2021 Jul;
19(8):2089.
PMID: 34327822
No abstract available.
15.
Bavalia R, Bistervels I, Boersma W, Quere I, Brisot D, Falvo N, et al.
Res Pract Thromb Haemost
. 2021 Jul;
5(5):e12566.
PMID: 34278193
Background: Long-term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has...
16.
Kovacs M, Wells P, Anderson D, Lazo-Langner A, Kearon C, Bates S, et al.
BMJ
. 2021 Jun;
373:n1205.
PMID: 34108229
Objective: To determine the efficacy and safety of dalteparin postoperative bridging treatment versus placebo for patients with atrial fibrillation or mechanical heart valves when warfarin is temporarily interrupted for a...
17.
Kawata E, Siew D, Payne J, Louzada M, Kovacs M, Lazo-Langner A
Thromb Res
. 2021 Apr;
202:90-95.
PMID: 33798804
Background: Clinical manifestations and optimal management strategies in patients with splanchnic vein thrombosis (SVT) are not well characterized. Methods: We conducted a retrospective cohort study including all newly diagnosed SVT...
18.
Aziz D, Skeith L, Rodger M, Sabri E, Righini M, Kovacs M, et al.
J Thromb Haemost
. 2021 Mar;
19(6):1526-1532.
PMID: 33724705
Introduction: The risk of recurrent venous thromboembolism (VTE) after combined oral contraceptive (COC) use is variably reported. We assessed the long-term risk of recurrent VTE in women on COC at...
19.
Kovacs M, Lazo-Langner A, Louzada M, Kovacs M
Thromb Res
. 2020 Aug;
195:231-232.
PMID: 32799129
No abstract available.
20.
Kovacs M, Lazo-Langner A, Kovacs M
Thromb Res
. 2020 Aug;
194:119-120.
PMID: 32788103
No abstract available.